sulfasalazine has been researched along with Adenocarcinoma, Endometrioid in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulfasalazine treatment significantly decreased intracellular glutathione levels and induced apoptosis when combined with cisplatin in USC cell lines." | 1.72 | Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer. ( Nagase, S; Ohta, T; Seino, M; Sendo, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sendo, K | 1 |
| Seino, M | 1 |
| Ohta, T | 1 |
| Nagase, S | 1 |
1 other study available for sulfasalazine and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Topics: Amino Acid Transport System y+; Antioxidants; Antiporters; Carcinoma, Endometrioid; Cell Line, Tumor | 2022 |